SARA BUTLER: Open Payments
NPI 1306228309 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 46 payments from 19 companies in 2025. Trend: 2023 $1,419 · 2024 $1,639 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $340 |
| United Therapeutics Corporation | 4 | $97 |
| GENZYME CORPORATION | 2 | $83 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Grifols USA, LLC | 2 | $60 |
| HARMONY BIOSCIENCES LLC | 2 | $41 |
| ABBVIE INC. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: BREZTRI, DUPIXENT, FASENRA, TEZSPIRE, NUCALA, Prolastin-C Liquid, Tyvaso, OFEV.
Industry payments across IA — which companies pay providers there.
